References
- Neiger R. Long-term effects of pregnancy complications on maternal health: a review. J Clin Med. 2017;6(8). pii: E76.
- Vogel JP, Souza JP, Mori R, et al. Maternal complications and perinatal mortality: findings of the World Health Organization multicountry survey on maternal and newborn health. BJOG. 2014;121(Suppl 1):76–88.
- Cuffe JSM, Holland O, Salomon C, et al. Review: placental derived biomarkers of pregnancy disorders. Placenta. 2017;54:104–110.
- Locktich G. Clinical biochemistry of pregnancy. Crit Rev Clin Lab Sci. 1997;34:6.
- Manokhina I, Wilson SL, Robinson WP. Noninvasive nucleic acid-based approaches to monitor placental health and predict pregnancy-related complications. Am J Obstet Gynecol. 2015;213(4):S197–S206.
- Sifakis S, Koukou Z, Spandidos DA. Cell-free fetal DNA and pregnancy-related complications (review). Mol Med Rep. 2015;11(4):2367–2372.
- Cretoiu D, Xu J, Xiao J, et al. Circulating microRNAs as potential molecular biomarkers in pathophysiological evolution of pregnancy. Dis Markers. 2016;2016:1.
- Montagnana M, Danese E, Lippi G, et al. Blood laboratory testing for early prediction of preeclampsia: chasing the finish line or at the starting blocks? Ann Med. 2017;49(3):240–253.
- Jairajpuri DS, Malalla ZH, Mahmood N, et al. Circulating microRNA expression as predictor of preeclampsia and its severity. Gene. 2017;627:543–548.
- Qin W, Tang Y, Yang N, et al. Potential role of circulating microRNAs as a biomarker for unexplained recurrent spontaneous abortion. Fertil Steril. 2016;105(5):1247–1254.e3.
- Qu S, Yang X, Li X, et al. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365(2):141–148.
- Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388.
- Chim SS, Shing TK, Hung EC, et al. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem. 2008;54(3):482–490.
- Lü L, Sun J, Shi P, et al. Identification of circular RNAs as a promising new class of diagnostic biomarkers for human breast cancer. Oncotarget. 2017;8(27):44096–44107.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta C(T)) method. Methods. 2001;25(4):402–408.
- Ilekis JV, Tsilou E, Fisher S, et al. Placental origins of adverse pregnancy outcomes: potential molecular targets: an executive workshop summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Am J Obstet Gynecol. 2016;215(1):S1–S46.
- Vashukova ES, Glotov AS, Fedotov PV, et al. Placental microRNA expression in pregnancies complicated by superimposed pre-eclampsia on chronic hypertension. Mol Med Rep. 2016;14(1):22–32.
- Ark M, Yilmaz N, Yazici G, et al. Rho-associated protein kinase II (rock II) expression in normal and preeclamptic human placentas. Placenta. 2005;26(1):81–84.
- Lartey J, López Bernal A. Rho protein regulation of contraction in the human uterus. Reproduction. 2009;138(3):407–424.
- Ietta F, Wu Y, Winter J, et al. Dynamic HIF1A regulation during human placental development. Biol Reprod. 2006;75(1):112–121.
- Bounds KR, Chiasson VL, Pan LJ, et al. MicroRNAs: new players in the pathobiology of preeclampsia. Front Cardiovasc Med. 2017;4:60.
- Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–338.
- Xia Q, Ding T, Zhang G, et al. Circular RNA expression profiling identifies prostate cancer- specific circRNAs in prostate cancer. Cell Physiol Biochem. 2018;50(5):1903–1915.
- Quan G, Li J. Circular RNAs: biogenesis, expression and their potential roles in reproduction. J Ovarian Res. 2018;11(1):9.
- Qian Y, Lu Y, Rui C, et al. Potential significance of circular RNA in human placental tissue for patients with preeclampsia. Cell Physiol Biochem. 2016;39(4):1380–1390.
- Wang W, Feng L, Zhang H, et al. Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, –20a, and –20b) that target ephrin-B2 and EPHB4 in human placenta. J Clin Endocrinol Metab. 2012;97(6):E1051–E1059.
- Zhang YG, Yang HL, Long Y, et al. Circular RNA in blood corpuscles combined with plasma protein factor for early prediction of pre-eclampsia. BJOG: Int J Obstet Gynecol. 2016;123(13):2113–2118.
- Prefumo F. Circular RNA and pre-eclampsia: on the long road from the laboratory to the bedside. BJOG: Int J Obstet Gynecol. 2016;123(13):2119.
- Lippi G, Simundic AM. The preanalytical phase in the era of high-throughput genetic testing. What the future holds. Diagnosis (Berl). 2019;6:73–74.
- Tian F, Shen Y, Chen Z, et al. No significant difference between plasma miRNAs and plasma-derived exosomal miRNAs from healthy people. Biomed Res Int. 2017;2017:1.
- Zavesky L, Jandakova E, Turyna R, et al. Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers. Neoplasma. 2016;63(01):121–132.
- Chevillet JR, Kang Q, Ruf IK, et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci USA. 2014;111(41):14888–14893.